19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Privately held drug developer Actavis Group Inc. said Friday it received Food and Drug Administration approval for generic versions of the antidepressant Wellbutrin and the smoking cessation drug Zyban.
The generic drug maker said it will start shipping the drugs immediately.
Canada-based Biovail Corp. makes Wellbutrin, which is sold by U.K.-based GlaxoSmithKline Plc. Zyban is made by GlaxoSmithKline.
GlaxoSmithKline reported Wellbutrin sales of 529 million British pounds ($1.05 billion) for 2007.
In afternoon trading, shares of Biovail fell 25 cents to $10.67 while GlaxoSmithKline fell 22 cents to $42.36.
NAME_Timothy F. Geithner AGE-BIRTH DATE-LOCATION-47; August 18, 1961, New York City.
U.S stocks fell on Wednesday as investors grew concerned that a bailout loan package for ailing automakers would fail to be approved by U.S. lawm...
As of Friday, Nov. 21, 2008, at least 556 members of the U.S. military had died in Afghanistan, Pakistan and Uzbekistan as a result of the U.S. i...
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
-0.19
0.31
